Check out our most popular compounded medications! Get Started
Description: Dehydroepiandrosterone (DHEA) 25 mg Slow Release Oral Capsules are a specialized formulation designed to provide a controlled release of DHEA, an endogenous steroid hormone, over an extended period. Each capsule contains 25 mg of DHEA embedded within Methocel E4M, a hydrophilic matrix that forms a gel barrier upon contact with gastrointestinal fluids. This matrix modulates the release of DHEA, ensuring a steady absorption rate and maintaining consistent plasma levels of the hormone. The slow release mechanism offers the advantage of reduced dosing frequency, which can enhance patient adherence to the treatment regimen.
The DHEA 25 mg Slow Release Capsules are indicated for the treatment of various conditions associated with DHEA deficiency. This includes adrenal insufficiency, where the body's production of DHEA is below normal, and certain age-related conditions where DHEA supplementation may contribute to an improved sense of well-being, increased muscle mass, and enhanced immune function. Additionally, these capsules may be used in the management of systemic lupus erythematosus (SLE), as some studies suggest that DHEA may help improve symptoms and reduce flare-ups in this autoimmune disease. The slow release formulation is particularly beneficial in these disease states, as it ensures a consistent therapeutic effect throughout the day without the need for multiple doses.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone that serves as a precursor to androgens and estrogens, which are vital for a wide range of physiological functions. Our formulation of DHEA 25 mg Slow Release (MEM4) Oral Capsules is meticulously designed to provide a steady release of DHEA over an extended period, utilizing Methocel E4M. This hydrophilic polymer swells and forms a gel upon contact with gastrointestinal fluids, creating a barrier that controls the rate at which the active ingredient is released into the bloodstream. This controlled-release mechanism ensures a consistent therapeutic level of DHEA, minimizing the fluctuations associated with immediate-release formulations.
The slow-release profile of our DHEA capsules offers several benefits, including reduced dosing frequency, which can significantly improve patient compliance, especially for those who may struggle with multiple daily dosages. By maintaining a more stable serum concentration, our formulation may also reduce the potential for side effects and enhance the overall efficacy of the treatment. DHEA supplementation has been studied for its potential role in a variety of conditions, including adrenal insufficiency, depression, osteoporosis, and systemic lupus erythematosus, among others. It is thought to exert beneficial effects by modulating the immune system, improving bone density, and influencing mood and energy levels.
It is important for prescribers to consider the individual patient's hormonal profile and potential interactions with other medications when recommending DHEA supplementation. Monitoring of DHEA serum levels may be advisable to tailor the dosage to the patient's specific needs. Patients should be informed about the gradual onset of action due to the slow-release nature of the capsules and should adhere to the prescribed dosing schedule for optimal results.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medication solutions. Our team is available to answer any questions and provide additional information to both patients and healthcare providers interested in our DHEA 25 mg Slow Release (MEM4) Oral Capsules. Please do not hesitate to reach out to us for guidance on this formulation or any other compounding needs.
Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone that serves as a precursor to androgens and estrogens, which are vital for a wide range of physiological functions. DHEA supplementation is used for conditions such as adrenal insufficiency, depression, induction of labor, and systemic lupus erythematosus, among others. However, it is important to consider potential drug interactions when prescribing or taking DHEA, especially in a slow-release formulation such as the one encapsulated with Methocel E4M.
Firstly, DHEA may interact with medications that are metabolized by the liver. Since DHEA is metabolized by cytochrome P450 enzymes, particularly CYP3A4, it may affect the metabolism of other drugs that are substrates of this enzyme. This can lead to either increased or decreased levels of these medications, potentially altering their efficacy and safety. Patients taking medications such as certain anticonvulsants, immunosuppressants, or protease inhibitors should be monitored closely when starting or adjusting the dose of DHEA.
Additionally, because DHEA can be converted into estrogen and testosterone, it may interact with hormone therapies, including birth control pills, hormone replacement therapy, or anti-estrogenic agents. The use of DHEA with these medications may necessitate adjustments in dosing or increased monitoring for side effects. For example, DHEA may potentially reduce the effectiveness of estrogen-based contraceptives, leading to an increased risk of unintended pregnancy.
Patients with hormone-sensitive conditions, such as breast cancer, prostate cancer, or endometriosis, should use DHEA with caution, as it may exacerbate these conditions. It is crucial to consult with a healthcare provider before starting DHEA if there is a history of hormone-sensitive diseases.
Furthermore, DHEA may interact with anticoagulants or antiplatelet medications, such as warfarin or aspirin. Since DHEA has been reported to have anticoagulant properties, combining it with these medications could potentially increase the risk of bleeding. Patients on blood thinners should have their clotting status monitored regularly if they are taking DHEA.
It is also important to note that the slow-release formulation of DHEA with Methocel E4M may alter the timing of drug interactions due to the prolonged release of the active ingredient. This could lead to a sustained interaction with other medications over a longer period than would be expected with an immediate-release formulation.
Patients should be advised to inform their healthcare providers of all medications, supplements, and herbal products they are taking to ensure safe and appropriate use of DHEA. Regular monitoring and possibly adjusting the dosage of other medications may be necessary when starting or changing the dose of DHEA slow-release capsules.
If you have any questions or require further information regarding the drug interactions associated with Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance.
Dehydroepiandrosterone (DHEA) is a naturally occurring hormone produced by the adrenal glands, which serves as a precursor to male and female sex hormones. The 25 mg slow-release oral capsules of DHEA are specifically designed to mimic the body's natural rhythm of hormone release, providing a steady supply of DHEA throughout the day. This is particularly beneficial for individuals whose bodies may not produce adequate levels of DHEA due to various health conditions or age-related decline.
The slow-release mechanism of these capsules is achieved through the incorporation of Methocel E4M, a hydrophilic methylcellulose derivative. Methocel E4M is a high-viscosity grade of hypromellose, which forms a gel-like matrix when it comes into contact with gastric fluids. This matrix creates a barrier around the active ingredient, controlling the rate at which DHEA is released from the capsule and absorbed into the bloodstream. The controlled-release polymer ensures a gradual and consistent release of DHEA, which can help maintain stable hormone levels, reduce the potential for side effects, and minimize the peaks and troughs associated with immediate-release formulations.
By providing a sustained release of DHEA, these capsules can help in the management of various conditions where DHEA supplementation has been deemed appropriate. This includes adrenal insufficiency, where the adrenal glands do not produce enough hormones, and certain conditions that affect mood, bone density, and sexual function. The slow-release formulation may also be beneficial for individuals looking to improve overall well-being and those seeking the anti-aging effects attributed to DHEA supplementation, such as improved skin health and immune function.
It is important for both patients and prescribers to understand that while DHEA supplementation can offer benefits for certain conditions, it should be used under medical supervision. The slow-release formulation of DHEA in these capsules is designed to provide a more consistent hormonal environment, which can be particularly advantageous for long-term therapy. However, individual responses to hormone therapy can vary, and monitoring by a healthcare professional is essential to ensure safety and efficacy.
For patients and prescribers interested in using this DHEA slow-release formulation, it is crucial to consider the patient's overall health status, current medications, and specific treatment goals. If you have any questions about the formulation, its mechanism of action, or its appropriateness for a particular patient, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to provide guidance and support for your unique healthcare needs.
This is a medication that contains 25 milligrams of Dehydroepiandrosterone (DHEA), formulated with Methocel E4M. It is designed to release DHEA gradually over an extended period to provide sustained therapeutic effects.
Methocel E4M is a type of controlled-release polymer used to formulate capsules that release their active ingredients slowly over time, allowing for consistent medication levels in the bloodstream.
The slow release formula provides a steady release of DHEA, offering sustained therapeutic effects, which can lead to improved outcomes, reduced dosing frequency, and enhanced patient compliance.
Your healthcare provider will advise you on how often to take the MEM4 Oral Capsule based on your individual health needs. Due to its controlled-release properties, the dosing frequency might be less compared to immediate-release formulations.
Yes, the MEM4 Oral Capsules can be taken with or without food. However, it is important to follow any specific instructions from your healthcare provider regarding the intake of this medication.
No, you should not open the capsules. Doing so can interfere with the slow-release mechanism and potentially alter the effectiveness and safety of the medication. If you have difficulty swallowing, consult your healthcare provider for alternatives.
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double doses. Always consult your healthcare provider for more specific guidance.
As with any medication, there may be side effects. Common side effects can include skin reactions, hormonal imbalances, and mood changes. Severe side effects are rare but should be reported to a healthcare professional immediately.
It's important to discuss all your current medications with your healthcare provider to ensure there are no adverse interactions when taken alongside Dehydroepiandrosterone 25 mg Slow Release capsules.
Store the capsules at room temperature, away from moisture and light, and keep them out of reach of children and pets. Do not store in the bathroom or freeze the medication.
Yes, you will need a prescription from a licensed healthcare provider to obtain Dehydroepiandrosterone 25 mg Slow Release (MEM4) Oral Capsules.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
